A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma

Bortezomib-melphalan-prednisone (VMP) showed superior efficacy versus MP as first-line treatment for transplantation-ineligible multiple myeloma (MM). This study investigated the efficacy of VMP for Korean patients with MM. Overall, 177 MM patients received 9 cycles of VMP in this prospective, multi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Kim, Min Kyoung, Kim, Kihyun, Min, Chang-Ki, Kwak, Jae-Yong, Bae, Sang-Byung, Yoon, Sung-Soo, Lee, Je-Jung, Kim, Ki Hwan, Nam, Seung-Hyun, Mun, Yeung-Chul, Kim, Hyo Jung, Bae, Sung Hwa, Shin, Ho-Jin, Lee, Jung-Hee, Park, Joon Seong, Jeong, Seong Hyun, Lee, Mark Hong, Kim, Yang-Soo, Lee, Ho Sup, Park, Keon Woo, Lee, Won-Sik, Lee, Sang Min, Lee, Jeong-Ok, Hyun, Myung Soo, Jo, Deog Yeon, Lim, Sung-Nam, Lee, Jae Hoon, Cho, Do-Yeun, Do, Young Rok, Kim, Jeong-A, Park, Seong Kyu, Kim, Jin Seok, Kim, Soo-Jeong, Kim, Hawk, Yi, Hyeon Gyu, Moon, Joon Ho, Choi, Chul Won, Kim, Sung-Hyun, Joo, Young-Don, Kim, Hoon-Gu, Kim, Byung Soo, Park, Moo-Rim, Song, Moo-Kon, Kim, Su-Youn
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5514934/
https://ncbi.nlm.nih.gov/pubmed/28402945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16790
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados